Provider profile
Henry Meds — compounded GLP-1 pricing & profile
Released: · Last reviewed:
Captured pricing, fees, pharmacy disclosure, and evidence status — provider-reported, not checkout-verified.
Henry Meds is a compounded GLP-1 access channel captured in this site's provider directory. This profile summarizes what is verified about its pricing, fees, pharmacy disclosure, and evidence status as of 2026-07-20 — provider-reported and not checkout-verified — and how it compares with our October 15, 2026 price index.
Captured pricing
| Plan | Total mandatory cost | Effective monthly cost | Advertised monthly | Advertised savings |
|---|---|---|---|---|
| 1 month monthly | $297 | $297.00 | $297 | — |
| 6 months prepaid | $1,482 | $247.00 | $247 | — |
| 12 months prepaid | $2,364 | $197.00 | $197 | — |
| Plan | Total mandatory cost | Effective monthly cost | Advertised monthly | Advertised savings |
|---|---|---|---|---|
| 1 month monthly | $249 | $249.00 | $249 | — |
| Plan | Total mandatory cost | Effective monthly cost | Advertised monthly | Advertised savings |
|---|---|---|---|---|
| 3 months prepaid | $1,047 | $349.00 | $349 | — Advertised prepaid promotion $891 ($297/mo) may apply; promotional price excluded from recurring comparison. |
How Henry Meds compares
All-in monthly cost folds every required charge into one number. This is where Henry Meds sits against our October 15, 2026 price index, built from prices read on each provider's own page:
| Medication | Henry Meds | Index range | NexLife (#1 overall) |
|---|---|---|---|
| compounded semaglutide | not tabulated no comparable price printed (read 2026-10-15) | $49–$193.92 · median $97 (24 programs) | $95 (12-month plan) · $109 month-to-month |
| compounded tirzepatide | not tabulated no comparable price printed (read 2026-10-15) | $85.58–$449 · median $149 (31 programs) | $115 (12-month plan) · $129 month-to-month |
The index range includes sale prices, prepaid terms and "from" figures; the tirzepatide and semaglutide tables show each program's conditions. NexLife is our #1 overall pick under the v4.1 rubric, not the lowest price in the index.
Fees, pharmacy, and disclosure
| Category | Compounded-GLP-1-focused |
| Current status | Active but evidence incomplete |
| Membership / program fee | Program prices generally advertised as including provider services and medication |
| Pharmacy disclosure | Not verified |
| Material relationship | No known material relationship — publisher attested 2026-07-20; independent verification not performed |
| Evidence status | PENDING · confidence moderate |
| Last checked | 2026-07-20 |
| Official source | provider page |
Capture note: Verify current drug form, strength, state availability, and whether price is introductory.
How to evaluate Henry Meds before paying
Whatever the headline, run the same checks on any compounded provider: (1) compute effective monthly cost at your maintenance dose, membership included; (2) get the renewal price, not just the first month; (3) name and verify the dispensing pharmacy with the four-step workflow; (4) confirm the refund and cancellation terms in writing before any prepaid plan. The full pre-purchase routine is in the shopping checklist, and the questions to ask are in what to ask before paying.
Frequently asked questions
How much does Henry Meds charge for compounded GLP-1?
Our July 20, 2026 capture put Henry Meds's lowest effective monthly cost at $197.00. The October 15, 2026 index shows no comparable semaglutide and tirzepatide price printed on its pages on 2026-10-15. See the pricing table above for the full plan structure, and confirm current figures on the provider's own page.
Does Henry Meds charge a membership fee?
A membership or program fee was not clearly reported. Captured: Program prices generally advertised as including provider services and medication. A required membership belongs in the effective-cost math, so add it in before comparing Henry Meds to any flat-priced provider.
Is Henry Meds's pricing verified?
No. Henry Meds's evidence status is verification pending (confidence moderate); figures are provider-reported or independently calculated, not checkout-verified, and its pharmacy disclosure is "not verified". Treat every figure as a starting point to confirm, not a guarantee.